Diabetes-care experts discuss key topics related to prescribing basal insulin Tresiba® for adult patients. Subjects include evaluating efficacy and safety data, the duration of action, and the features of Tresiba® FlexTouch®.
Tresiba® (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba® is not recommended for treating diabetic ketoacidosis or for pediatric patients requiring less than 5 units of Tresiba®.
Please click here for Prescribing Information.